TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma-Reference-Cited by-同舟云学术

TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma

Published:2015-06-22 Issue:18 Volume:6 Page:16663-16673
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Mosrati Mohamed Ali¹,Malmström Annika²,Lysiak Malgorzata¹,Krysztofiak Adam¹,Hallbeck Martin³,Milos Peter⁴,Hallbeck Anna-Lotta⁵,Bratthäll Charlotte⁶,Strandéus Michael⁷,Stenmark-Askmalm Marie⁸,Söderkvist Peter¹

Affiliation:

1. Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

2. Department of Advanced Home Care and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

3. Department of Clinical Pathology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

4. Department of Neurosurgery and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

5. Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

6. Department of Oncology, District Hospital, Kalmar, Sweden

7. Department of Oncology, Ryhov Hospital, Jönköping, Sweden

8. Department of Clinical Pathology and Clinical Genetics and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naringenin Nanoformulations for Neurodegenerative Diseases;Current Pharmaceutical Biotechnology;2024-12

2. Interleukin 6 and cancer resistance in glioblastoma multiforme;Neurosurgical Review;2024-09-05

3. A Synopsis of Biomarkers in Glioblastoma: Past and Present;Current Issues in Molecular Biology;2024-07-03

4. Glioblastoma Vaccines as Promising Immune-Therapeutics: Challenges and Current Status;Vaccines;2024-06-12

5. Prognostic Impact of TERT Promoter Mutations in Adult-Type Diffuse Gliomas Based on WHO2021 Criteria;Cancers;2024-05-27